CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Shares withheld for taxes Pres., Functional Regeneration gave up 3,272 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,396 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Exec Vice President gave up 7,035 shares (to pay taxes)
- 8-K Event Material agreement · Unregistered share sale
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 4 Option exercise 10% owner acquired 1,188,255 shares (option exercise)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 8-K Event Agreement ended
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- 4 Grant or award Director acquired 67,416 shares (grant or award)
Page 7 of 29 · 563 filings